Obesity Predicts Survival After Cardiac Resynchronization Therapy Independent of Effect on Left Ventricular Ejection Fraction.
暂无分享,去创建一个
M. Niebauer | O. Wazni | B. Wilkoff | R. Starling | N. Varma | K. Tarakji | Anirudh Kumar | J. Rickard | Wilson Tang | Daniel J. Cantillon | Nishant P. Shah | Divyang R Patel | D. Cantillon | Kevin M. Trulock | E. Donnellan | Z. Il'giovine | Bálint Laczay | Laurie Ann Moennich | Nishant P. Shah
[1] P. Heidenreich,et al. Body mass index and outcomes of cardiac resynchronization with implantable cardioverter‐defibrillator therapy in older patients with heart failure , 2019, European journal of heart failure.
[2] D. Logeart,et al. High body mass index is a predictor of left ventricular reverse remodelling in heart failure with reduced ejection fraction , 2017, ESC heart failure.
[3] M. Niebauer,et al. Echocardiographic Predictors of Long‐Term Survival in Patients Undergoing Cardiac Resynchronization Therapy: What Is the Optimal Metric? , 2017, Journal of cardiovascular electrophysiology.
[4] S. Rathore,et al. The obesity paradox: body mass index and outcomes in patients with heart failure. , 2005, Archives of internal medicine.
[5] P. Ponikowski,et al. Wasting as independent risk factor for mortality in chronic heart failure , 1997, The Lancet.